ERBB2 and prostate adenocarcinoma: We benchmarked CellPie against published dimensionality reduction methods on two human cancer ST datasets, a Visium 10x Genomics human prostate adenocarcinoma with invasive carcinoma and an ST HER2 (human epidermal growth factor receptor 2)-positive human breast cancer sample.